BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28634077)

  • 1. DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer.
    Huang L; Chen K; Cai ZP; Chen FC; Shen HY; Zhao WH; Yang SJ; Chen XB; Tang GX; Lin X
    Biochem Biophys Res Commun; 2017 Aug; 490(3):707-712. PubMed ID: 28634077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.
    Kikuchi R; Sampetrean O; Saya H; Yoshida K; Toda M
    J Neurooncol; 2017 Jun; 133(2):297-307. PubMed ID: 28555424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC.
    Zhang L; Du Y; Xu S; Jiang Y; Yuan C; Zhou L; Ma X; Bai Y; Lu J; Ma J
    Cancer Lett; 2019 Feb; 442():242-251. PubMed ID: 30419349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DEP Domain Containing 1 Promotes Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Colorectal Cancer by Enhancing Expression of Suppressor of Zest 12.
    Wang Q; Jiang S; Liu J; Ma G; Zheng J; Zhang Y
    Cancer Biother Radiopharm; 2021 Feb; 36(1):36-44. PubMed ID: 32343606
    [No Abstract]   [Full Text] [Related]  

  • 5. DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis.
    Qu D; Cui F; Lu D; Yang Y; Xu Y
    Cancer Sci; 2019 Jan; 110(1):157-165. PubMed ID: 30417471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
    Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
    Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
    Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C
    Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEPDC1 upregulation promotes cell proliferation and predicts poor prognosis in patients with gastric cancer.
    Gong Z; Chu H; Chen J; Jiang L; Gong B; Zhu P; Zhang C; Wang Z; Zhang W; Wang J; Li C; Zhao H
    Cancer Biomark; 2021; 30(3):299-307. PubMed ID: 33361586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis.
    Kanehira M; Harada Y; Takata R; Shuin T; Miki T; Fujioka T; Nakamura Y; Katagiri T
    Oncogene; 2007 Sep; 26(44):6448-55. PubMed ID: 17452976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation].
    Shen J; Xi M
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):453-460. PubMed ID: 34134185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells.
    Harada Y; Kanehira M; Fujisawa Y; Takata R; Shuin T; Miki T; Fujioka T; Nakamura Y; Katagiri T
    Cancer Res; 2010 Jul; 70(14):5829-39. PubMed ID: 20587513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
    Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The secreted matrix protein mindin increases prostate tumor progression and tumor-bone crosstalk via ERK 1/2 regulation.
    Ardura JA; Gutiérrez-Rojas I; Álvarez-Carrión L; Rodríguez-Ramos MR; Pozuelo JM; Alonso V
    Carcinogenesis; 2019 Jul; 40(7):828-839. PubMed ID: 31168562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of DEPDC1 at Ser110 is required to maintain centrosome organization during mitosis.
    Chen D; Ito S; Hyodo T; Asano-Inami E; Yuan H; Senga T
    Exp Cell Res; 2017 Sep; 358(2):101-110. PubMed ID: 28602627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DEPDC1 as a crucial factor in the progression of human osteosarcoma.
    Shen L; Li H; Liu R; Zhou C; Bretches M; Gong X; Lu L; Zhang Y; Zhao K; Ning B; Yang SY; Zhang A
    Cancer Med; 2023 Mar; 12(5):5798-5808. PubMed ID: 36479633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEPDC1 up-regulates RAS expression to inhibit autophagy in lung adenocarcinoma cells.
    Wang W; Li A; Han X; Wang Q; Guo J; Wu Y; Wang C; Huang G
    J Cell Mol Med; 2020 Nov; 24(22):13303-13313. PubMed ID: 33021072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXO3a‑modulated DEPDC1 promotes malignant progression of nephroblastoma via the Wnt/β‑catenin signaling pathway.
    Geng G; Li Q; Guo X; Ni Q; Xu Y; Ma Z; Wang Y; Ming M
    Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35795985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
    Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing eL31 suppresses the progression of colorectal cancer via targeting DEPDC1.
    Sharen G; Li X; Sun J; Zhang L; Xi W; Zhao X; Han F; Jia L; A R; Cheng H; Hou M
    J Transl Med; 2022 Oct; 20(1):493. PubMed ID: 36309731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.